Cannell & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $392K | Buy |
672
+267
| +66% | +$156K | 0.01% | 221 |
|
|
2023
Q3 | $218K | Sell |
405
-1,525
| -79% | -$786K | 0.01% | 240 |
|
|
2023
Q2 | $905K | Buy |
1,930
+25
| +1% | +$10.5K | 0.03% | 173 |
|
|
2023
Q1 | $654K | Sell |
1,905
-95
| -5% | -$32K | 0.02% | 188 |
|
|
2022
Q4 | $732K | Buy |
2,000
+30
| +2% | +$10.6K | 0.03% | 183 |
|
|
2022
Q3 | $637K | Hold |
1,970
| – | – | 0.02% | 190 |
|
|
2022
Q2 | $639K | Sell |
1,970
-30
| -2% | -$9.01K | 0.02% | 193 |
|
|
2022
Q1 | $573K | Hold |
2,000
| – | – | 0.02% | 213 |
|
|
2021
Q4 | $552K | Hold |
2,000
| – | – | 0.02% | 220 |
|
|
2021
Q3 | $462K | Hold |
2,000
| – | – | 0.01% | 229 |
|
|
2021
Q2 | $459K | Hold |
2,000
| – | – | 0.01% | 226 |
|
|
2021
Q1 | $374K | Hold |
2,000
| – | – | 0.01% | 234 |
|
|
2020
Q4 | $338K | Sell |
2,000
-50
| -2% | -$7.46K | 0.01% | 231 |
|
|
2020
Q3 | $303K | Sell |
2,050
-50
| -2% | -$7.74K | 0.01% | 215 |
|
|
2020
Q2 | $345K | Hold |
2,100
| – | – | 0.01% | 202 |
|
|
2020
Q1 | $291K | Hold |
2,100
| – | – | 0.01% | 199 |
|
|
2019
Q4 | $276K | Hold |
2,100
| – | – | 0.01% | 213 |
|
|
2019
Q3 | $235K | Hold |
2,100
| – | – | 0.01% | 217 |
|
|
2019
Q2 | $233K | Sell |
2,100
-100
| -5% | -$11.8K | 0.01% | 220 |
|
|
2019
Q1 | $285K | Sell |
2,200
-7,535
| -77% | -$916K | 0.01% | 221 |
|
|
2018
Q4 | $1.13M | Hold |
9,735
| – | – | 0.05% | 147 |
|
|
2018
Q3 | $1.04M | Sell |
9,735
-100
| -1% | -$10K | 0.04% | 163 |
|
|
2018
Q2 | $839K | Hold |
9,835
| – | – | 0.03% | 177 |
|
|
2018
Q1 | $761K | Hold |
9,835
| – | – | 0.03% | 181 |
|
|
2017
Q4 | $831K | Hold |
9,835
| – | – | 0.03% | 178 |
|
|
2017
Q3 | $841K | Sell |
9,835
-150
| -2% | -$12.3K | 0.03% | 177 |
|
|
2017
Q2 | $822K | Sell |
9,985
-40
| -0.4% | -$3.26K | 0.03% | 175 |
|
|
2017
Q1 | $843K | Buy |
10,025
+40
| +0.4% | +$3.2K | 0.03% | 183 |
|
|
2016
Q4 | $734K | Hold |
9,985
| – | – | 0.03% | 181 |
|
|
2016
Q3 | $801K | Hold |
9,985
| – | – | 0.03% | 180 |
|
|
2016
Q2 | $786K | Sell |
9,985
-100
| -1% | -$7.53K | 0.03% | 180 |
|
|
2016
Q1 | $726K | Sell |
10,085
-1,444
| -13% | -$109K | 0.03% | 185 |
|
|
2015
Q4 | $971K | Hold |
11,529
| – | – | 0.03% | 172 |
|
|
2015
Q3 | $965K | Hold |
11,529
| – | – | 0.03% | 178 |
|
|
2015
Q2 | $963K | Hold |
11,529
| – | – | 0.03% | 175 |
|
|
2015
Q1 | $838K | Sell |
11,529
-250
| -2% | -$17.8K | 0.02% | 176 |
|
|
2014
Q4 | $813K | Hold |
11,779
| – | – | 0.02% | 179 |
|
|
2014
Q3 | $764K | Hold |
11,779
| – | – | 0.02% | 184 |
|
|
2014
Q2 | $732K | Hold |
11,779
| – | – | 0.02% | 189 |
|
|
2014
Q1 | $693K | Buy |
+11,779
| New | +$657K | 0.02% | 195 |
|
Other funds holding LLY
Cannell & Co's LLY Position: Q4 2023 in Review
Cannell & Co increased its Eli Lilly (LLY) stake by 66% in Q4 2023, buying an estimated $156K and bringing the position to 672 shares worth $392K. The position accounts for 0.01% of the portfolio, ranked #221.
Cannell & Co first reported a position in LLY in Q1 2014 and has held it in 40 quarters since. The position peaked at $1.13M in Q4 2018. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.
- Cannell & Co held 672 shares of Eli Lilly worth $392K as of Q4 2023.
- Cannell & Co bought 267 Eli Lilly shares in Q4 2023, an estimated $156K.
- Eli Lilly made up 0.01% of Cannell & Co's portfolio in Q4 2023, its #221 holding.
- Cannell & Co first reported a position in Eli Lilly in Q1 2014 and has held it in 40 quarters since.
- Cannell & Co's Eli Lilly position peaked at $1.13M in Q4 2018.
- 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.
Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.